TE

SEC source: 0001213900-25-126050 · marketforms-71694.xml · derivative · entry 2

Lin Mingxing · CIK 0002049819 · Director · Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Shares of Common Stock · 250,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: The RSUs were granted pursuant to the 2021 Equity Incentive Plan (as amended and restated on April 22, 2024).

F1 · derivative.exercise_price: This transaction represents the net settlement of restricted stock units ("RSUs") in shares of Common Stock on their scheduled vesting date. The RSUs were granted on December 23, 2024 and fully vested on December 23, 2025. Each RSU represents the right to receive, at settlement, one share of Common Stock.

F1 · price: This transaction represents the net settlement of restricted stock units ("RSUs") in shares of Common Stock on their scheduled vesting date. The RSUs were granted on December 23, 2024 and fully vested on December 23, 2025. Each RSU represents the right to receive, at settlement, one share of Common Stock.

F1 · derivative.exercise_date: This transaction represents the net settlement of restricted stock units ("RSUs") in shares of Common Stock on their scheduled vesting date. The RSUs were granted on December 23, 2024 and fully vested on December 23, 2025. Each RSU represents the right to receive, at settlement, one share of Common Stock.

F1 · derivative.expiration_date: This transaction represents the net settlement of restricted stock units ("RSUs") in shares of Common Stock on their scheduled vesting date. The RSUs were granted on December 23, 2024 and fully vested on December 23, 2025. Each RSU represents the right to receive, at settlement, one share of Common Stock.

SEC source: 0001213900-25-126050 · marketforms-71694.xml · nonDerivative · entry 1

Lin Mingxing · CIK 0002049819 · Director · Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 381,800

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This transaction represents the net settlement of restricted stock units ("RSUs") in shares of Common Stock on their scheduled vesting date. The RSUs were granted on December 23, 2024 and fully vested on December 23, 2025. Each RSU represents the right to receive, at settlement, one share of Common Stock.

F1 · price: This transaction represents the net settlement of restricted stock units ("RSUs") in shares of Common Stock on their scheduled vesting date. The RSUs were granted on December 23, 2024 and fully vested on December 23, 2025. Each RSU represents the right to receive, at settlement, one share of Common Stock.

F2 · balance_after: The number of securities shown as beneficially owned following the reported transaction reflects (i) 131,800 shares of Common Stock previously reported as beneficially owned by the reporting person on the Form 3 filed on January 2, 2025, plus (ii) 250,000 shares of Common Stock issued upon vesting and net share settlement of the RSUs reported herein.

SEC source: 0000912282-25-001474 · form4.xml · derivative · entry 3

TRINA SOLAR (SCHWEIZ) AG · CIK 0002047012 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,918,460 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: As reported in the Form 8-K filed by the Issuer on 12/27/24, on 12/23/24, in connection with an acquisition transaction, the Issuer issued to the Reporting Person a 7% convertible note (the ?Note?). Subject to approval by the Committee on Foreign Investment in the United States ("CFIUS"), the Note was convertible by the Reporting Person into (i) 12,521,653 shares of common stock of the Issuer (the "First Conversion") and (ii) an additional 17,918,460 shares of common stock of the Issuer (the "Second Conversion"). The Second Conversion was subject to approval by the Issuer's stockholders. On 5/27/25, the Issuer received a CFIUS letter determining that the transaction was not a covered transaction under Section 721 of the Defense Production Act of 1950, as amended, and therefore was not subject to review by CFIUS. The First Conversion occurred on 9/5/25. The Issuer's stockholders approved the Second Conversion on 12/3/25, and the Second Conversion occurred on 12/10/25.

F1 · price: As reported in the Form 8-K filed by the Issuer on 12/27/24, on 12/23/24, in connection with an acquisition transaction, the Issuer issued to the Reporting Person a 7% convertible note (the ?Note?). Subject to approval by the Committee on Foreign Investment in the United States ("CFIUS"), the Note was convertible by the Reporting Person into (i) 12,521,653 shares of common stock of the Issuer (the "First Conversion") and (ii) an additional 17,918,460 shares of common stock of the Issuer (the "Second Conversion"). The Second Conversion was subject to approval by the Issuer's stockholders. On 5/27/25, the Issuer received a CFIUS letter determining that the transaction was not a covered transaction under Section 721 of the Defense Production Act of 1950, as amended, and therefore was not subject to review by CFIUS. The First Conversion occurred on 9/5/25. The Issuer's stockholders approved the Second Conversion on 12/3/25, and the Second Conversion occurred on 12/10/25.

F1 · derivative.exercise_date: As reported in the Form 8-K filed by the Issuer on 12/27/24, on 12/23/24, in connection with an acquisition transaction, the Issuer issued to the Reporting Person a 7% convertible note (the ?Note?). Subject to approval by the Committee on Foreign Investment in the United States ("CFIUS"), the Note was convertible by the Reporting Person into (i) 12,521,653 shares of common stock of the Issuer (the "First Conversion") and (ii) an additional 17,918,460 shares of common stock of the Issuer (the "Second Conversion"). The Second Conversion was subject to approval by the Issuer's stockholders. On 5/27/25, the Issuer received a CFIUS letter determining that the transaction was not a covered transaction under Section 721 of the Defense Production Act of 1950, as amended, and therefore was not subject to review by CFIUS. The First Conversion occurred on 9/5/25. The Issuer's stockholders approved the Second Conversion on 12/3/25, and the Second Conversion occurred on 12/10/25.

F1 · derivative.expiration_date: As reported in the Form 8-K filed by the Issuer on 12/27/24, on 12/23/24, in connection with an acquisition transaction, the Issuer issued to the Reporting Person a 7% convertible note (the ?Note?). Subject to approval by the Committee on Foreign Investment in the United States ("CFIUS"), the Note was convertible by the Reporting Person into (i) 12,521,653 shares of common stock of the Issuer (the "First Conversion") and (ii) an additional 17,918,460 shares of common stock of the Issuer (the "Second Conversion"). The Second Conversion was subject to approval by the Issuer's stockholders. On 5/27/25, the Issuer received a CFIUS letter determining that the transaction was not a covered transaction under Section 721 of the Defense Production Act of 1950, as amended, and therefore was not subject to review by CFIUS. The First Conversion occurred on 9/5/25. The Issuer's stockholders approved the Second Conversion on 12/3/25, and the Second Conversion occurred on 12/10/25.

SEC source: 0000912282-25-001474 · form4.xml · nonDerivative · entry 1

TRINA SOLAR (SCHWEIZ) AG · CIK 0002047012 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,877,960

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: As reported in the Form 8-K filed by the Issuer on 12/27/24, on 12/23/24, in connection with an acquisition transaction, the Issuer issued to the Reporting Person a 7% convertible note (the ?Note?). Subject to approval by the Committee on Foreign Investment in the United States ("CFIUS"), the Note was convertible by the Reporting Person into (i) 12,521,653 shares of common stock of the Issuer (the "First Conversion") and (ii) an additional 17,918,460 shares of common stock of the Issuer (the "Second Conversion"). The Second Conversion was subject to approval by the Issuer's stockholders. On 5/27/25, the Issuer received a CFIUS letter determining that the transaction was not a covered transaction under Section 721 of the Defense Production Act of 1950, as amended, and therefore was not subject to review by CFIUS. The First Conversion occurred on 9/5/25. The Issuer's stockholders approved the Second Conversion on 12/3/25, and the Second Conversion occurred on 12/10/25.

SEC source: 0000912282-25-001474 · form4.xml · derivative · entry 2

TRINA SOLAR (SCHWEIZ) AG · CIK 0002047012 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,400,000

Underlying: Common Stock · 30,400,000 shares

Expires not disclosed

F1 · derivative.exercise_price: As reported in the Form 8-K filed by the Issuer on 12/27/24, on 12/23/24, in connection with an acquisition transaction, the Issuer issued to the Reporting Person a 7% convertible note (the ?Note?). Subject to approval by the Committee on Foreign Investment in the United States ("CFIUS"), the Note was convertible by the Reporting Person into (i) 12,521,653 shares of common stock of the Issuer (the "First Conversion") and (ii) an additional 17,918,460 shares of common stock of the Issuer (the "Second Conversion"). The Second Conversion was subject to approval by the Issuer's stockholders. On 5/27/25, the Issuer received a CFIUS letter determining that the transaction was not a covered transaction under Section 721 of the Defense Production Act of 1950, as amended, and therefore was not subject to review by CFIUS. The First Conversion occurred on 9/5/25. The Issuer's stockholders approved the Second Conversion on 12/3/25, and the Second Conversion occurred on 12/10/25.

F1 · kind: As reported in the Form 8-K filed by the Issuer on 12/27/24, on 12/23/24, in connection with an acquisition transaction, the Issuer issued to the Reporting Person a 7% convertible note (the ?Note?). Subject to approval by the Committee on Foreign Investment in the United States ("CFIUS"), the Note was convertible by the Reporting Person into (i) 12,521,653 shares of common stock of the Issuer (the "First Conversion") and (ii) an additional 17,918,460 shares of common stock of the Issuer (the "Second Conversion"). The Second Conversion was subject to approval by the Issuer's stockholders. On 5/27/25, the Issuer received a CFIUS letter determining that the transaction was not a covered transaction under Section 721 of the Defense Production Act of 1950, as amended, and therefore was not subject to review by CFIUS. The First Conversion occurred on 9/5/25. The Issuer's stockholders approved the Second Conversion on 12/3/25, and the Second Conversion occurred on 12/10/25.

F1 · price: As reported in the Form 8-K filed by the Issuer on 12/27/24, on 12/23/24, in connection with an acquisition transaction, the Issuer issued to the Reporting Person a 7% convertible note (the ?Note?). Subject to approval by the Committee on Foreign Investment in the United States ("CFIUS"), the Note was convertible by the Reporting Person into (i) 12,521,653 shares of common stock of the Issuer (the "First Conversion") and (ii) an additional 17,918,460 shares of common stock of the Issuer (the "Second Conversion"). The Second Conversion was subject to approval by the Issuer's stockholders. On 5/27/25, the Issuer received a CFIUS letter determining that the transaction was not a covered transaction under Section 721 of the Defense Production Act of 1950, as amended, and therefore was not subject to review by CFIUS. The First Conversion occurred on 9/5/25. The Issuer's stockholders approved the Second Conversion on 12/3/25, and the Second Conversion occurred on 12/10/25.

F1 · derivative.exercise_date: As reported in the Form 8-K filed by the Issuer on 12/27/24, on 12/23/24, in connection with an acquisition transaction, the Issuer issued to the Reporting Person a 7% convertible note (the ?Note?). Subject to approval by the Committee on Foreign Investment in the United States ("CFIUS"), the Note was convertible by the Reporting Person into (i) 12,521,653 shares of common stock of the Issuer (the "First Conversion") and (ii) an additional 17,918,460 shares of common stock of the Issuer (the "Second Conversion"). The Second Conversion was subject to approval by the Issuer's stockholders. On 5/27/25, the Issuer received a CFIUS letter determining that the transaction was not a covered transaction under Section 721 of the Defense Production Act of 1950, as amended, and therefore was not subject to review by CFIUS. The First Conversion occurred on 9/5/25. The Issuer's stockholders approved the Second Conversion on 12/3/25, and the Second Conversion occurred on 12/10/25.

F1 · derivative.expiration_date: As reported in the Form 8-K filed by the Issuer on 12/27/24, on 12/23/24, in connection with an acquisition transaction, the Issuer issued to the Reporting Person a 7% convertible note (the ?Note?). Subject to approval by the Committee on Foreign Investment in the United States ("CFIUS"), the Note was convertible by the Reporting Person into (i) 12,521,653 shares of common stock of the Issuer (the "First Conversion") and (ii) an additional 17,918,460 shares of common stock of the Issuer (the "Second Conversion"). The Second Conversion was subject to approval by the Issuer's stockholders. On 5/27/25, the Issuer received a CFIUS letter determining that the transaction was not a covered transaction under Section 721 of the Defense Production Act of 1950, as amended, and therefore was not subject to review by CFIUS. The First Conversion occurred on 9/5/25. The Issuer's stockholders approved the Second Conversion on 12/3/25, and the Second Conversion occurred on 12/10/25.

SEC source: 0001213900-25-117937 · ownership.xml · nonDerivative · entry 1

Lin Mingxing · CIK 0002049819 · Director · Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 131,800

F1 · shares: Consists of RSUs vested on the date of issuance that will be net settled in shares of Common Stock.

F2 · shares: Each RSU represents a right to receive one share of Common Stock granted pursuant to the 2021 Equity Incentive Plan (amended and restated as of April 22, 2024).

F3 · balance_after: Consists of RSUs vested immediately upon grant. One-third (1/3) of the units shall be released on December 1, 2026. One-third (1/3) of the units shall be released on December 1, 2027. One-third (1/3) of the units shall be released on December 1, 2028.

SEC source: 0001213900-25-117924 · ownership.xml · nonDerivative · entry 1

Slettemoen Tore Ivar · CIK 0002020977 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

F1 · shares: Consists of RSUs vested on the date of issuance that will be net settled in shares of Common Stock.

F2 · shares: Each RSU represents a right to receive one share of Common Stock granted pursuant to the 2021 Equity Incentive Plan (amended and restated as of April 22, 2024).

F3 · ownership.direct: Consists of RSUs vested immediately upon grant. One-third (1/3) of the units shall be released on December 1, 2026. One-third (1/3) of the units shall be released on December 1, 2027. One-third (1/3) of the units shall be released on December 1, 2028.

SEC source: 0001213900-25-117925 · ownership.xml · nonDerivative · entry 1

Manners David J. · CIK 0002020938 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,379

F1 · shares: Consists of RSUs vested on the date of issuance that will be net settled in shares of Common Stock.

F2 · shares: Each RSU represents a right to receive one share of Common Stock granted pursuant to the 2021 Equity Incentive Plan (amended and restated as of April 22, 2024).

F3 · balance_after: Consists of RSUs vested immediately upon grant. One-third (1/3) of the units shall be released on December 1, 2026. One-third (1/3) of the units shall be released on December 1, 2027. One-third (1/3) of the units shall be released on December 1, 2028.

SEC source: 0001213900-25-117923 · ownership.xml · nonDerivative · entry 1

Strine Jessica Wirth · CIK 0002005683 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

F1 · shares: Consists of RSUs vested on the date of issuance that will be net settled in shares of Common Stock.

F2 · shares: Each RSU represents a right to receive one share of Common Stock granted pursuant to the 2021 Equity Incentive Plan (amended and restated as of April 22, 2024).

F3 · balance_after: Consists of RSUs vested immediately upon grant. One-third (1/3) of the units shall be released on December 1, 2026. One-third (1/3) of the units shall be released on December 1, 2027. One-third (1/3) of the units shall be released on December 1, 2028.

SEC source: 0001213900-25-118017 · ownership.xml · nonDerivative · entry 1

Steingart Daniel · CIK 0002005839 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

F1 · shares: Consists of RSUs vested on the date of issuance that will be net settled in shares of Common Stock.

F2 · shares: Each RSU represents a right to receive one share of Common Stock granted pursuant to the 2021 Equity Incentive Plan (amended and restated as of April 22, 2024).

F3 · balance_after: Consists of RSUs vested immediately upon grant. One-third (1/3) of the units shall be released on December 1, 2026. One-third (1/3) of the units shall be released on December 1, 2027. One-third (1/3) of the units shall be released on December 1, 2028.

SEC source: 0001213900-25-118018 · ownership.xml · nonDerivative · entry 1

ANDERSON W RICHARD · CIK 0001288047 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

F1 · shares: Consists of RSUs vested on the date of issuance that will be net settled in shares of Common Stock.

F2 · shares: Each RSU represents a right to receive one share of Common Stock granted pursuant to the 2021 Equity Incentive Plan (amended and restated as of April 22, 2024).

F3 · balance_after: Consists of RSUs vested immediately upon grant. One-third (1/3) of the units shall be released on December 1, 2026. One-third (1/3) of the units shall be released on December 1, 2027. One-third (1/3) of the units shall be released on December 1, 2028.

SEC source: 0001213900-25-118001 · ownership.xml · nonDerivative · entry 1

Barcelo Daniel · CIK 0001786389 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,008,333

F1 · shares: Consists of RSUs vested on the date of issuance that will be net settled in shares of Common Stock.

F2 · shares: Each RSU represents a right to receive one share of Common Stock granted pursuant to the 2021 Equity Incentive Plan (amended and restated as of April 22, 2024).

F3 · balance_after: Consists of RSUs vested immediately upon grant. One-third (1/3) of the units shall be released on December 1, 2026. One-third (1/3) of the units shall be released on December 1, 2027. One-third (1/3) of the units shall be released on December 1, 2028.

SEC source: 0001213900-25-118000 · ownership.xml · nonDerivative · entry 1

Matrai Balazs Peter · CIK 0001991928 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,623,912

F1 · shares: Consists of RSUs vested on the date of issuance that will be net settled in shares of Common Stock.

F2 · shares: Each RSU represents a right to receive one share of Common Stock granted pursuant to the 2021 Equity Incentive Plan (amended and restated as of April 22, 2024).

F3 · balance_after: Consists of RSUs vested immediately upon grant. One-third (1/3) of the units shall be released on December 1, 2026. One-third (1/3) of the units shall be released on December 1, 2027. One-third (1/3) of the units shall be released on December 1, 2028.

SEC source: 0001213900-25-114423 · ownership.xml · derivative · entry 1

Gualy Jaime Eduardo · CIK 0002083231 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 375,000

Underlying: Common Stock · 100,000 shares

Expires not disclosed

F1 · derivative.exercise_price: The RSUs will be net settled in shares of Common Stock.

F2 · derivative.exercise_price: Each RSU represents a right to receive one share of Common Stock granted pursuant to the 2021 Equity Incentive Plan (amended and restated as of April 22, 2024).

F3 · derivative.exercise_date: The RSUs will vest ratably over three years from the November 4, 2025 grant date. One-third (1/3) of the units shall vest on November 4, 2026. One-third (1/3) of the units shall vest on November 4, 2027. One-third (1/3) of the units shall vest on November 4, 2028.

F3 · derivative.expiration_date: The RSUs will vest ratably over three years from the November 4, 2025 grant date. One-third (1/3) of the units shall vest on November 4, 2026. One-third (1/3) of the units shall vest on November 4, 2027. One-third (1/3) of the units shall vest on November 4, 2028.

SEC source: 0000921895-25-002885 · form409900010_11042025.xml · derivative · entry 4

Encompass Capital Advisors LLC · CIK 0001541901 · Director · 10% owner · See Remarks

Kantor Todd J. · CIK 0002021082 · Director · 10% owner · See Remarks

Encompass Capital Partners LLC · CIK 0002050318 · Director · 10% owner · See Remarks

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000,000

Underlying: Common Stock · 29,411,764 shares

Expires 2027-12-23

F1 · security: This Form 4 is filed jointly by Todd Kantor, Encompass Capital Advisors LLC ("ECA") and Encompass Capital Partners LLC ("ECP" and, together with Mr. Kantor and ECA, collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a Section 13(d) group. Each of the Reporting Persons disclaims beneficial ownership of the securities of the Issuer owned directly by other members of the Section 13(d) group and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Further, each of the Reporting Persons disclaims beneficial ownership of the shares of Common Stock reported herein except to the extent of his or its pecuniary interest therein.

F2 · derivative.exercise_price: On October 31, 2025, the Issuer entered into an Amended and Restated Stock Purchase Agreement (the "SPA") with the purchasers party thereto. Pursuant to the SPA, in partial consideration for the redemption and cancellation of all then-issued and outstanding Series A Convertible Preferred Stock, the purchasers received (i) 21,504,901 shares of the Issuer's common stock (the "Common Stock") and (ii) 1,600,000 shares of the Company's Series B Convertible Non-Voting Preferred Stock (the "Series B Preferred Stock"). The purchasers also purchased 5,000,000 shares of the Issuer's Series B-1 Convertible Non-Voting Preferred Stock (the "Series B-1 Preferred Stock" and together with the Series B Preferred Stock, the "Preferred Stock"), at a price of $10.00 per share. The SPA amends and restates the Preferred Stock Purchase Agreement by and between the Company and the purchasers thereto, dated as of November 6, 2024 (as amended).

F3 · derivative.exercise_price: Each share of Preferred Stock is convertible at any time into a number of shares of Common Stock equal to the sum of the issue price ($10.00) plus any accrued but unpaid dividends divided by the conversion price (initially $1.70) as set forth in the applicable certificate of designations. The certificate of designations for each of the Preferred Stock prohibits conversion to the extent that the holder would beneficially own in excess of 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of such Preferred Stock.

F2 · price: On October 31, 2025, the Issuer entered into an Amended and Restated Stock Purchase Agreement (the "SPA") with the purchasers party thereto. Pursuant to the SPA, in partial consideration for the redemption and cancellation of all then-issued and outstanding Series A Convertible Preferred Stock, the purchasers received (i) 21,504,901 shares of the Issuer's common stock (the "Common Stock") and (ii) 1,600,000 shares of the Company's Series B Convertible Non-Voting Preferred Stock (the "Series B Preferred Stock"). The purchasers also purchased 5,000,000 shares of the Issuer's Series B-1 Convertible Non-Voting Preferred Stock (the "Series B-1 Preferred Stock" and together with the Series B Preferred Stock, the "Preferred Stock"), at a price of $10.00 per share. The SPA amends and restates the Preferred Stock Purchase Agreement by and between the Company and the purchasers thereto, dated as of November 6, 2024 (as amended).

F2 · derivative.exercise_date: On October 31, 2025, the Issuer entered into an Amended and Restated Stock Purchase Agreement (the "SPA") with the purchasers party thereto. Pursuant to the SPA, in partial consideration for the redemption and cancellation of all then-issued and outstanding Series A Convertible Preferred Stock, the purchasers received (i) 21,504,901 shares of the Issuer's common stock (the "Common Stock") and (ii) 1,600,000 shares of the Company's Series B Convertible Non-Voting Preferred Stock (the "Series B Preferred Stock"). The purchasers also purchased 5,000,000 shares of the Issuer's Series B-1 Convertible Non-Voting Preferred Stock (the "Series B-1 Preferred Stock" and together with the Series B Preferred Stock, the "Preferred Stock"), at a price of $10.00 per share. The SPA amends and restates the Preferred Stock Purchase Agreement by and between the Company and the purchasers thereto, dated as of November 6, 2024 (as amended).

F3 · derivative.exercise_date: Each share of Preferred Stock is convertible at any time into a number of shares of Common Stock equal to the sum of the issue price ($10.00) plus any accrued but unpaid dividends divided by the conversion price (initially $1.70) as set forth in the applicable certificate of designations. The certificate of designations for each of the Preferred Stock prohibits conversion to the extent that the holder would beneficially own in excess of 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of such Preferred Stock.

F2 · ownership.direct: On October 31, 2025, the Issuer entered into an Amended and Restated Stock Purchase Agreement (the "SPA") with the purchasers party thereto. Pursuant to the SPA, in partial consideration for the redemption and cancellation of all then-issued and outstanding Series A Convertible Preferred Stock, the purchasers received (i) 21,504,901 shares of the Issuer's common stock (the "Common Stock") and (ii) 1,600,000 shares of the Company's Series B Convertible Non-Voting Preferred Stock (the "Series B Preferred Stock"). The purchasers also purchased 5,000,000 shares of the Issuer's Series B-1 Convertible Non-Voting Preferred Stock (the "Series B-1 Preferred Stock" and together with the Series B Preferred Stock, the "Preferred Stock"), at a price of $10.00 per share. The SPA amends and restates the Preferred Stock Purchase Agreement by and between the Company and the purchasers thereto, dated as of November 6, 2024 (as amended).

F3 · ownership.direct: Each share of Preferred Stock is convertible at any time into a number of shares of Common Stock equal to the sum of the issue price ($10.00) plus any accrued but unpaid dividends divided by the conversion price (initially $1.70) as set forth in the applicable certificate of designations. The certificate of designations for each of the Preferred Stock prohibits conversion to the extent that the holder would beneficially own in excess of 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of such Preferred Stock.

SEC source: 0000921895-25-002885 · form409900010_11042025.xml · derivative · entry 3

Encompass Capital Advisors LLC · CIK 0001541901 · Director · 10% owner · See Remarks

Kantor Todd J. · CIK 0002021082 · Director · 10% owner · See Remarks

Encompass Capital Partners LLC · CIK 0002050318 · Director · 10% owner · See Remarks

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,600,000

Underlying: Common Stock · 9,411,764 shares

Expires 2027-12-23

F1 · security: This Form 4 is filed jointly by Todd Kantor, Encompass Capital Advisors LLC ("ECA") and Encompass Capital Partners LLC ("ECP" and, together with Mr. Kantor and ECA, collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a Section 13(d) group. Each of the Reporting Persons disclaims beneficial ownership of the securities of the Issuer owned directly by other members of the Section 13(d) group and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Further, each of the Reporting Persons disclaims beneficial ownership of the shares of Common Stock reported herein except to the extent of his or its pecuniary interest therein.

F2 · derivative.exercise_price: On October 31, 2025, the Issuer entered into an Amended and Restated Stock Purchase Agreement (the "SPA") with the purchasers party thereto. Pursuant to the SPA, in partial consideration for the redemption and cancellation of all then-issued and outstanding Series A Convertible Preferred Stock, the purchasers received (i) 21,504,901 shares of the Issuer's common stock (the "Common Stock") and (ii) 1,600,000 shares of the Company's Series B Convertible Non-Voting Preferred Stock (the "Series B Preferred Stock"). The purchasers also purchased 5,000,000 shares of the Issuer's Series B-1 Convertible Non-Voting Preferred Stock (the "Series B-1 Preferred Stock" and together with the Series B Preferred Stock, the "Preferred Stock"), at a price of $10.00 per share. The SPA amends and restates the Preferred Stock Purchase Agreement by and between the Company and the purchasers thereto, dated as of November 6, 2024 (as amended).

F3 · derivative.exercise_price: Each share of Preferred Stock is convertible at any time into a number of shares of Common Stock equal to the sum of the issue price ($10.00) plus any accrued but unpaid dividends divided by the conversion price (initially $1.70) as set forth in the applicable certificate of designations. The certificate of designations for each of the Preferred Stock prohibits conversion to the extent that the holder would beneficially own in excess of 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of such Preferred Stock.

F2 · price: On October 31, 2025, the Issuer entered into an Amended and Restated Stock Purchase Agreement (the "SPA") with the purchasers party thereto. Pursuant to the SPA, in partial consideration for the redemption and cancellation of all then-issued and outstanding Series A Convertible Preferred Stock, the purchasers received (i) 21,504,901 shares of the Issuer's common stock (the "Common Stock") and (ii) 1,600,000 shares of the Company's Series B Convertible Non-Voting Preferred Stock (the "Series B Preferred Stock"). The purchasers also purchased 5,000,000 shares of the Issuer's Series B-1 Convertible Non-Voting Preferred Stock (the "Series B-1 Preferred Stock" and together with the Series B Preferred Stock, the "Preferred Stock"), at a price of $10.00 per share. The SPA amends and restates the Preferred Stock Purchase Agreement by and between the Company and the purchasers thereto, dated as of November 6, 2024 (as amended).

F2 · derivative.exercise_date: On October 31, 2025, the Issuer entered into an Amended and Restated Stock Purchase Agreement (the "SPA") with the purchasers party thereto. Pursuant to the SPA, in partial consideration for the redemption and cancellation of all then-issued and outstanding Series A Convertible Preferred Stock, the purchasers received (i) 21,504,901 shares of the Issuer's common stock (the "Common Stock") and (ii) 1,600,000 shares of the Company's Series B Convertible Non-Voting Preferred Stock (the "Series B Preferred Stock"). The purchasers also purchased 5,000,000 shares of the Issuer's Series B-1 Convertible Non-Voting Preferred Stock (the "Series B-1 Preferred Stock" and together with the Series B Preferred Stock, the "Preferred Stock"), at a price of $10.00 per share. The SPA amends and restates the Preferred Stock Purchase Agreement by and between the Company and the purchasers thereto, dated as of November 6, 2024 (as amended).

F3 · derivative.exercise_date: Each share of Preferred Stock is convertible at any time into a number of shares of Common Stock equal to the sum of the issue price ($10.00) plus any accrued but unpaid dividends divided by the conversion price (initially $1.70) as set forth in the applicable certificate of designations. The certificate of designations for each of the Preferred Stock prohibits conversion to the extent that the holder would beneficially own in excess of 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of such Preferred Stock.

F2 · ownership.direct: On October 31, 2025, the Issuer entered into an Amended and Restated Stock Purchase Agreement (the "SPA") with the purchasers party thereto. Pursuant to the SPA, in partial consideration for the redemption and cancellation of all then-issued and outstanding Series A Convertible Preferred Stock, the purchasers received (i) 21,504,901 shares of the Issuer's common stock (the "Common Stock") and (ii) 1,600,000 shares of the Company's Series B Convertible Non-Voting Preferred Stock (the "Series B Preferred Stock"). The purchasers also purchased 5,000,000 shares of the Issuer's Series B-1 Convertible Non-Voting Preferred Stock (the "Series B-1 Preferred Stock" and together with the Series B Preferred Stock, the "Preferred Stock"), at a price of $10.00 per share. The SPA amends and restates the Preferred Stock Purchase Agreement by and between the Company and the purchasers thereto, dated as of November 6, 2024 (as amended).

F3 · ownership.direct: Each share of Preferred Stock is convertible at any time into a number of shares of Common Stock equal to the sum of the issue price ($10.00) plus any accrued but unpaid dividends divided by the conversion price (initially $1.70) as set forth in the applicable certificate of designations. The certificate of designations for each of the Preferred Stock prohibits conversion to the extent that the holder would beneficially own in excess of 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of such Preferred Stock.

SEC source: 0000921895-25-002885 · form409900010_11042025.xml · derivative · entry 2

Encompass Capital Advisors LLC · CIK 0001541901 · Director · 10% owner · See Remarks

Kantor Todd J. · CIK 0002021082 · Director · 10% owner · See Remarks

Encompass Capital Partners LLC · CIK 0002050318 · Director · 10% owner · See Remarks

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 0 shares

Expires not disclosed

F1 · security: This Form 4 is filed jointly by Todd Kantor, Encompass Capital Advisors LLC ("ECA") and Encompass Capital Partners LLC ("ECP" and, together with Mr. Kantor and ECA, collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a Section 13(d) group. Each of the Reporting Persons disclaims beneficial ownership of the securities of the Issuer owned directly by other members of the Section 13(d) group and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Further, each of the Reporting Persons disclaims beneficial ownership of the shares of Common Stock reported herein except to the extent of his or its pecuniary interest therein.

F2 · derivative.exercise_price: On October 31, 2025, the Issuer entered into an Amended and Restated Stock Purchase Agreement (the "SPA") with the purchasers party thereto. Pursuant to the SPA, in partial consideration for the redemption and cancellation of all then-issued and outstanding Series A Convertible Preferred Stock, the purchasers received (i) 21,504,901 shares of the Issuer's common stock (the "Common Stock") and (ii) 1,600,000 shares of the Company's Series B Convertible Non-Voting Preferred Stock (the "Series B Preferred Stock"). The purchasers also purchased 5,000,000 shares of the Issuer's Series B-1 Convertible Non-Voting Preferred Stock (the "Series B-1 Preferred Stock" and together with the Series B Preferred Stock, the "Preferred Stock"), at a price of $10.00 per share. The SPA amends and restates the Preferred Stock Purchase Agreement by and between the Company and the purchasers thereto, dated as of November 6, 2024 (as amended).

F2 · price: On October 31, 2025, the Issuer entered into an Amended and Restated Stock Purchase Agreement (the "SPA") with the purchasers party thereto. Pursuant to the SPA, in partial consideration for the redemption and cancellation of all then-issued and outstanding Series A Convertible Preferred Stock, the purchasers received (i) 21,504,901 shares of the Issuer's common stock (the "Common Stock") and (ii) 1,600,000 shares of the Company's Series B Convertible Non-Voting Preferred Stock (the "Series B Preferred Stock"). The purchasers also purchased 5,000,000 shares of the Issuer's Series B-1 Convertible Non-Voting Preferred Stock (the "Series B-1 Preferred Stock" and together with the Series B Preferred Stock, the "Preferred Stock"), at a price of $10.00 per share. The SPA amends and restates the Preferred Stock Purchase Agreement by and between the Company and the purchasers thereto, dated as of November 6, 2024 (as amended).

F2 · derivative.exercise_date: On October 31, 2025, the Issuer entered into an Amended and Restated Stock Purchase Agreement (the "SPA") with the purchasers party thereto. Pursuant to the SPA, in partial consideration for the redemption and cancellation of all then-issued and outstanding Series A Convertible Preferred Stock, the purchasers received (i) 21,504,901 shares of the Issuer's common stock (the "Common Stock") and (ii) 1,600,000 shares of the Company's Series B Convertible Non-Voting Preferred Stock (the "Series B Preferred Stock"). The purchasers also purchased 5,000,000 shares of the Issuer's Series B-1 Convertible Non-Voting Preferred Stock (the "Series B-1 Preferred Stock" and together with the Series B Preferred Stock, the "Preferred Stock"), at a price of $10.00 per share. The SPA amends and restates the Preferred Stock Purchase Agreement by and between the Company and the purchasers thereto, dated as of November 6, 2024 (as amended).

F2 · derivative.expiration_date: On October 31, 2025, the Issuer entered into an Amended and Restated Stock Purchase Agreement (the "SPA") with the purchasers party thereto. Pursuant to the SPA, in partial consideration for the redemption and cancellation of all then-issued and outstanding Series A Convertible Preferred Stock, the purchasers received (i) 21,504,901 shares of the Issuer's common stock (the "Common Stock") and (ii) 1,600,000 shares of the Company's Series B Convertible Non-Voting Preferred Stock (the "Series B Preferred Stock"). The purchasers also purchased 5,000,000 shares of the Issuer's Series B-1 Convertible Non-Voting Preferred Stock (the "Series B-1 Preferred Stock" and together with the Series B Preferred Stock, the "Preferred Stock"), at a price of $10.00 per share. The SPA amends and restates the Preferred Stock Purchase Agreement by and between the Company and the purchasers thereto, dated as of November 6, 2024 (as amended).

F2 · ownership.direct: On October 31, 2025, the Issuer entered into an Amended and Restated Stock Purchase Agreement (the "SPA") with the purchasers party thereto. Pursuant to the SPA, in partial consideration for the redemption and cancellation of all then-issued and outstanding Series A Convertible Preferred Stock, the purchasers received (i) 21,504,901 shares of the Issuer's common stock (the "Common Stock") and (ii) 1,600,000 shares of the Company's Series B Convertible Non-Voting Preferred Stock (the "Series B Preferred Stock"). The purchasers also purchased 5,000,000 shares of the Issuer's Series B-1 Convertible Non-Voting Preferred Stock (the "Series B-1 Preferred Stock" and together with the Series B Preferred Stock, the "Preferred Stock"), at a price of $10.00 per share. The SPA amends and restates the Preferred Stock Purchase Agreement by and between the Company and the purchasers thereto, dated as of November 6, 2024 (as amended).

SEC source: 0000921895-25-002885 · form409900010_11042025.xml · nonDerivative · entry 1

Encompass Capital Advisors LLC · CIK 0001541901 · Director · 10% owner · See Remarks

Kantor Todd J. · CIK 0002021082 · Director · 10% owner · See Remarks

Encompass Capital Partners LLC · CIK 0002050318 · Director · 10% owner · See Remarks

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,968,169

F1 · security: This Form 4 is filed jointly by Todd Kantor, Encompass Capital Advisors LLC ("ECA") and Encompass Capital Partners LLC ("ECP" and, together with Mr. Kantor and ECA, collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a Section 13(d) group. Each of the Reporting Persons disclaims beneficial ownership of the securities of the Issuer owned directly by other members of the Section 13(d) group and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Further, each of the Reporting Persons disclaims beneficial ownership of the shares of Common Stock reported herein except to the extent of his or its pecuniary interest therein.

F2 · price: On October 31, 2025, the Issuer entered into an Amended and Restated Stock Purchase Agreement (the "SPA") with the purchasers party thereto. Pursuant to the SPA, in partial consideration for the redemption and cancellation of all then-issued and outstanding Series A Convertible Preferred Stock, the purchasers received (i) 21,504,901 shares of the Issuer's common stock (the "Common Stock") and (ii) 1,600,000 shares of the Company's Series B Convertible Non-Voting Preferred Stock (the "Series B Preferred Stock"). The purchasers also purchased 5,000,000 shares of the Issuer's Series B-1 Convertible Non-Voting Preferred Stock (the "Series B-1 Preferred Stock" and together with the Series B Preferred Stock, the "Preferred Stock"), at a price of $10.00 per share. The SPA amends and restates the Preferred Stock Purchase Agreement by and between the Company and the purchasers thereto, dated as of November 6, 2024 (as amended).

SEC source: 0001213900-25-091119 · ownership.xml · nonDerivative · entry 2

Slettemoen Tore Ivar · CIK 0002020977 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 4,105,457

F1 · ownership.nature: Teknovekst UK Ltd, incorporated in the United Kingdom ("Teknovekst UK"), directly holds 4,105,457 shares of Common Stock, whose sole shareholder is Teknovekst Invest AS, incorporated in Norway ("Teknovekst Invest"). Teknovekst AS, also incorporated in Norway, may be deemed to beneficially own the shares held by Teknovekst UK by virtue of its 99.9% ownership of Teknovekst Invest. Mr. Slettemoen is the sole owner of Teknovekst AS and disclaims beneficial ownership of the shares held by Teknovekst AS except to the extent of his pecuniary interest therein.

SEC source: 0001213900-25-091119 · ownership.xml · nonDerivative · entry 1

Slettemoen Tore Ivar · CIK 0002020977 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 4,481,563

F1 · ownership.nature: Teknovekst UK Ltd, incorporated in the United Kingdom ("Teknovekst UK"), directly holds 4,105,457 shares of Common Stock, whose sole shareholder is Teknovekst Invest AS, incorporated in Norway ("Teknovekst Invest"). Teknovekst AS, also incorporated in Norway, may be deemed to beneficially own the shares held by Teknovekst UK by virtue of its 99.9% ownership of Teknovekst Invest. Mr. Slettemoen is the sole owner of Teknovekst AS and disclaims beneficial ownership of the shares held by Teknovekst AS except to the extent of his pecuniary interest therein.

SEC source: 0001213900-25-087824 · ownership.xml · nonDerivative · entry 2

Slettemoen Tore Ivar · CIK 0002020977 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 4,865,912

F1 · ownership.nature: Teknovekst UK Ltd, incorporated in the United Kingdom ("Teknovekst UK"), directly holds 4,865,912 shares of Common Stock, whose sole shareholder is Teknovekst Invest AS, incorporated in Norway ("Teknovekst Invest"). Teknovekst AS, also incorporated in Norway, may be deemed to beneficially own the shares held by Teknovekst UK by virtue of its 99.9% ownership of Teknovekst Invest. Mr. Slettemoen is the sole owner of Teknovekst AS and disclaims beneficial ownership of the shares held by Teknovekst AS except to the extent of his pecuniary interest therein.

SEC source: 0001213900-25-087824 · ownership.xml · nonDerivative · entry 1

Slettemoen Tore Ivar · CIK 0002020977 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 5,054,332

F1 · ownership.nature: Teknovekst UK Ltd, incorporated in the United Kingdom ("Teknovekst UK"), directly holds 4,865,912 shares of Common Stock, whose sole shareholder is Teknovekst Invest AS, incorporated in Norway ("Teknovekst Invest"). Teknovekst AS, also incorporated in Norway, may be deemed to beneficially own the shares held by Teknovekst UK by virtue of its 99.9% ownership of Teknovekst Invest. Mr. Slettemoen is the sole owner of Teknovekst AS and disclaims beneficial ownership of the shares held by Teknovekst AS except to the extent of his pecuniary interest therein.

SEC source: 0001213900-25-082582 · ownership.xml · derivative · entry 3

Matrai Balazs Peter · CIK 0001991928 · Director

EDGE Global LLC · CIK 0002005780 · Please see remarks.

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Self as Co-Owner of EDGE Global LLC

Disclosed balance after: 0

Underlying: Shares of Common Stock · 687,219 shares

Expires 2025-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · ownership.nature: Mr. Matrai is a co-owner of EDGE Global and disclaims beneficial ownership of the warrants held by EDGE Global except to the extent of his pecuniary interest therein.

SEC source: 0001213900-25-082582 · ownership.xml · nonDerivative · entry 2

Matrai Balazs Peter · CIK 0001991928 · Director

EDGE Global LLC · CIK 0002005780 · Please see remarks.

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Self as Co-Owner of EDGE Global LLC

Disclosed balance after: 549,168

F1 · shares: On August 27, 2025, EDGE Global LLC ("EDGE Global"), exercised warrants to purchase 687,219 shares of common stock of the Issuer through cashless exercise, resulting in the withholding by the Issuer of 530,637 shares and issuing to EDGE Global the remaining 156,582 shares, based on the closing price of the Issuer's shares of common stock on August 27, 2025 of $1.58 per share.

F2 · ownership.nature: Mr. Matrai is a co-owner of EDGE Global and disclaims beneficial ownership of the warrants held by EDGE Global except to the extent of his pecuniary interest therein.

SEC source: 0001213900-25-082582 · ownership.xml · nonDerivative · entry 1

Matrai Balazs Peter · CIK 0001991928 · Director

EDGE Global LLC · CIK 0002005780 · Please see remarks.

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Self as Co-Owner of EDGE Global LLC

Disclosed balance after: 1,079,805

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On August 27, 2025, EDGE Global LLC ("EDGE Global"), exercised warrants to purchase 687,219 shares of common stock of the Issuer through cashless exercise, resulting in the withholding by the Issuer of 530,637 shares and issuing to EDGE Global the remaining 156,582 shares, based on the closing price of the Issuer's shares of common stock on August 27, 2025 of $1.58 per share.

F2 · ownership.nature: Mr. Matrai is a co-owner of EDGE Global and disclaims beneficial ownership of the warrants held by EDGE Global except to the extent of his pecuniary interest therein.

SEC source: 0001213900-25-094700 · ownership.xml · derivative · entry 1

Calio Joseph Evan · CIK 0002027475 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Shares of Common Stock · 300,000 shares

Expires 2030-08-20

F1 · derivative.exercise_date: Consists of compensatory options which vest annually over three years granted on August 20, 2025 pursuant to the 2021 Equity Incentive Plan (amended and restated as of April 22, 2024). Of the shares subject to compensatory options, one-third (1/3) vest on August 20, 2026, one-third (1/3) vest on August 20, 2027, and one-third (1/3) vest on August 20, 2028. Options are typically forfeited when the employment relationship ends for employees.

SEC source: 0000921895-25-002325 · form409900010_08152025.xml · derivative · entry 2

Encompass Capital Advisors LLC · CIK 0001541901 · Director · See Remarks

Kantor Todd J. · CIK 0002021082 · Director · See Remarks

Encompass Capital Partners LLC · CIK 0002050318 · Director · See Remarks

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000,000

Underlying: Common Stock · 29,411,765 shares

Expires 2027-12-23

F1 · security: This Form 4 is filed jointly by Todd Kantor, Encompass Capital Advisors LLC ("ECA") and Encompass Capital Partners LLC ("ECP" and, together with Mr. Kantor and ECA, collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a Section 13(d) group. Each of the Reporting Persons disclaims beneficial ownership of the securities of the Issuer owned directly by other members of the Section 13(d) group and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Further, each of the Reporting Persons disclaims beneficial ownership of the shares of Common Stock reported herein except to the extent of his or its pecuniary interest therein.

F2 · derivative.exercise_price: On August 13, 2025, the Issuer and certain funds and accounts managed by ECA entered into Amendment No. 3 to the Preferred Stock Purchase Agreement, pursuant to which the conversion price of the first tranche of Series A Convertible Preferred Stock, par value $0.01 per share ("Preferred Stock") was amended from $2.50 to $1.70 per share.

F3 · derivative.exercise_price: Each share of Preferred Stock is convertible at any time after December 23, 2025 into a number of shares of common stock of the Issuer ("Common Stock") equal to the sum of the issue price ($10.00) plus any accrued but unpaid dividends divided by the conversion price (initially $1.70). The certificate of designations of the Preferred Stock prohibits conversion to the extent that the holder would beneficially own in excess of 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of Preferred Stock.

F2 · derivative.exercise_date: On August 13, 2025, the Issuer and certain funds and accounts managed by ECA entered into Amendment No. 3 to the Preferred Stock Purchase Agreement, pursuant to which the conversion price of the first tranche of Series A Convertible Preferred Stock, par value $0.01 per share ("Preferred Stock") was amended from $2.50 to $1.70 per share.

F3 · derivative.exercise_date: Each share of Preferred Stock is convertible at any time after December 23, 2025 into a number of shares of common stock of the Issuer ("Common Stock") equal to the sum of the issue price ($10.00) plus any accrued but unpaid dividends divided by the conversion price (initially $1.70). The certificate of designations of the Preferred Stock prohibits conversion to the extent that the holder would beneficially own in excess of 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of Preferred Stock.

F2 · ownership.direct: On August 13, 2025, the Issuer and certain funds and accounts managed by ECA entered into Amendment No. 3 to the Preferred Stock Purchase Agreement, pursuant to which the conversion price of the first tranche of Series A Convertible Preferred Stock, par value $0.01 per share ("Preferred Stock") was amended from $2.50 to $1.70 per share.

F3 · ownership.direct: Each share of Preferred Stock is convertible at any time after December 23, 2025 into a number of shares of common stock of the Issuer ("Common Stock") equal to the sum of the issue price ($10.00) plus any accrued but unpaid dividends divided by the conversion price (initially $1.70). The certificate of designations of the Preferred Stock prohibits conversion to the extent that the holder would beneficially own in excess of 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of Preferred Stock.

SEC source: 0000921895-25-002325 · form409900010_08152025.xml · derivative · entry 1

Encompass Capital Advisors LLC · CIK 0001541901 · Director · See Remarks

Kantor Todd J. · CIK 0002021082 · Director · See Remarks

Encompass Capital Partners LLC · CIK 0002050318 · Director · See Remarks

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000,000 shares

Expires not disclosed

F1 · security: This Form 4 is filed jointly by Todd Kantor, Encompass Capital Advisors LLC ("ECA") and Encompass Capital Partners LLC ("ECP" and, together with Mr. Kantor and ECA, collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a Section 13(d) group. Each of the Reporting Persons disclaims beneficial ownership of the securities of the Issuer owned directly by other members of the Section 13(d) group and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Further, each of the Reporting Persons disclaims beneficial ownership of the shares of Common Stock reported herein except to the extent of his or its pecuniary interest therein.

F2 · derivative.exercise_price: On August 13, 2025, the Issuer and certain funds and accounts managed by ECA entered into Amendment No. 3 to the Preferred Stock Purchase Agreement, pursuant to which the conversion price of the first tranche of Series A Convertible Preferred Stock, par value $0.01 per share ("Preferred Stock") was amended from $2.50 to $1.70 per share.

F2 · derivative.exercise_date: On August 13, 2025, the Issuer and certain funds and accounts managed by ECA entered into Amendment No. 3 to the Preferred Stock Purchase Agreement, pursuant to which the conversion price of the first tranche of Series A Convertible Preferred Stock, par value $0.01 per share ("Preferred Stock") was amended from $2.50 to $1.70 per share.

F2 · derivative.expiration_date: On August 13, 2025, the Issuer and certain funds and accounts managed by ECA entered into Amendment No. 3 to the Preferred Stock Purchase Agreement, pursuant to which the conversion price of the first tranche of Series A Convertible Preferred Stock, par value $0.01 per share ("Preferred Stock") was amended from $2.50 to $1.70 per share.

F2 · ownership.direct: On August 13, 2025, the Issuer and certain funds and accounts managed by ECA entered into Amendment No. 3 to the Preferred Stock Purchase Agreement, pursuant to which the conversion price of the first tranche of Series A Convertible Preferred Stock, par value $0.01 per share ("Preferred Stock") was amended from $2.50 to $1.70 per share.

SEC source: 0001213900-25-070027 · ownership.xml · derivative · entry 1

Munro Andrew · CIK 0002066533 · Chief Legal & Policy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires not disclosed

F1 · derivative.exercise_price: The RSUs will be net settled in shares of Common Stock.

F2 · derivative.exercise_price: Each RSU represents a right to receive one share of Common Stock granted pursuant to the 2021 Equity Incentive Plan (amended and restated as of April 22, 2024).

F3 · derivative.exercise_date: The RSUs will vest ratably over three years from the July 29, 2025 grant date. One-third (1/3) of the units shall vest on July 29, 2026. One-third (1/3) of the units shall vest on July 29, 2027. One-third (1/3) of the units shall vest on July 29, 2028.

F3 · derivative.expiration_date: The RSUs will vest ratably over three years from the July 29, 2025 grant date. One-third (1/3) of the units shall vest on July 29, 2026. One-third (1/3) of the units shall vest on July 29, 2027. One-third (1/3) of the units shall vest on July 29, 2028.

SEC source: 0001213900-25-057828 · ownership.xml · derivative · entry 1

Kilde Einar · CIK 0002033804 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 210,000

Underlying: Common Stock · 210,000 shares

Expires not disclosed

F1 · derivative.exercise_price: The RSUs will be net settled in shares of Common Stock.

F2 · derivative.exercise_price: Each RSU represents a right to receive one share of Common Stock granted pursuant to the 2021 Equity Incentive Plan (amended and restated as of April 22, 2024).

F3 · derivative.exercise_date: The RSUs will vest ratably over three years from the June 23, 2025 grant date. One-third (1/3) of the units shall vest on June 23, 2026. One-third (1/3) of the units shall vest on June 23, 2027. One-third (1/3) of the units shall vest on June 23, 2028.

F3 · derivative.expiration_date: The RSUs will vest ratably over three years from the June 23, 2025 grant date. One-third (1/3) of the units shall vest on June 23, 2026. One-third (1/3) of the units shall vest on June 23, 2027. One-third (1/3) of the units shall vest on June 23, 2028.

SEC source: 0001213900-25-057829 · ownership.xml · derivative · entry 1

Calio Joseph Evan · CIK 0002027475 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 375,000

Underlying: Common Stock · 375,000 shares

Expires not disclosed

F1 · derivative.exercise_price: The RSUs will be net settled in shares of Common Stock.

F2 · derivative.exercise_price: Each RSU represents a right to receive one share of Common Stock granted pursuant to the 2021 Equity Incentive Plan (amended and restated as of April 22, 2024).

F3 · derivative.exercise_date: The RSUs will vest ratably over three years from the June 23, 2025 grant date. One-third (1/3) of the units shall vest on June 23, 2026. One-third (1/3) of the units shall vest on June 23, 2027. One-third (1/3) of the units shall vest on June 23, 2028.

F3 · derivative.expiration_date: The RSUs will vest ratably over three years from the June 23, 2025 grant date. One-third (1/3) of the units shall vest on June 23, 2026. One-third (1/3) of the units shall vest on June 23, 2027. One-third (1/3) of the units shall vest on June 23, 2028.

SEC source: 0001213900-25-057830 · ownership.xml · derivative · entry 1

Bentzen Andreas · CIK 0002005709 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires not disclosed

F1 · derivative.exercise_price: The RSUs will be net settled in shares of Common Stock.

F2 · derivative.exercise_price: Each RSU represents a right to receive one share of Common Stock granted pursuant to the 2021 Equity Incentive Plan (amended and restated as of April 22, 2024).

F3 · derivative.exercise_date: The RSUs will vest ratably over three years from the June 23, 2025 grant date. One-third (1/3) of the units shall vest on June 23, 2026. One-third (1/3) of the units shall vest on June 23, 2027. One-third (1/3) of the units shall vest on June 23, 2028.

F3 · derivative.expiration_date: The RSUs will vest ratably over three years from the June 23, 2025 grant date. One-third (1/3) of the units shall vest on June 23, 2026. One-third (1/3) of the units shall vest on June 23, 2027. One-third (1/3) of the units shall vest on June 23, 2028.

SEC source: 0001213900-26-039542 · marketforms-71773.xml · derivative · entry 6

Calio Joseph Evan · CIK 0002027475 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 844,952

Underlying: Shares of Common Stock · 422,475 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: This transaction represents the vesting on June 13, 2025 of 422,475 Restricted Stock Units ("RSUs") granted on June 13, 2024 under the Company's 2021 Equity Incentive Plan (as amended and restated on April 22, 2024) and reported on the Form 4 filed August 9, 2024. This relates to the vesting of the first of three equal annual installments (further details in Note 7 below). Each RSU represents the right to receive one share of Common Stock. These 422,475 RSUs were settled in shares of Common Stock on March 13, 2026.

F1 · price: This transaction represents the vesting on June 13, 2025 of 422,475 Restricted Stock Units ("RSUs") granted on June 13, 2024 under the Company's 2021 Equity Incentive Plan (as amended and restated on April 22, 2024) and reported on the Form 4 filed August 9, 2024. This relates to the vesting of the first of three equal annual installments (further details in Note 7 below). Each RSU represents the right to receive one share of Common Stock. These 422,475 RSUs were settled in shares of Common Stock on March 13, 2026.

F7 · derivative.exercise_date: The RSUs reported on the Form 4 filed August 9, 2024 were granted for a total of 1,267,427 RSUs vesting in three equal annual installments: one-third vested on June 13, 2025; one-third will vest on June 13, 2026; and the remaining one-third will vest on June 13, 2027. Following the vesting and settlement of the first installment reported herein, 844,952 RSUs remain outstanding.

F7 · derivative.expiration_date: The RSUs reported on the Form 4 filed August 9, 2024 were granted for a total of 1,267,427 RSUs vesting in three equal annual installments: one-third vested on June 13, 2025; one-third will vest on June 13, 2026; and the remaining one-third will vest on June 13, 2027. Following the vesting and settlement of the first installment reported herein, 844,952 RSUs remain outstanding.

F7 · balance_after: The RSUs reported on the Form 4 filed August 9, 2024 were granted for a total of 1,267,427 RSUs vesting in three equal annual installments: one-third vested on June 13, 2025; one-third will vest on June 13, 2026; and the remaining one-third will vest on June 13, 2027. Following the vesting and settlement of the first installment reported herein, 844,952 RSUs remain outstanding.

SEC source: 0001213900-26-039542 · marketforms-71773.xml · nonDerivative · entry 1

Calio Joseph Evan · CIK 0002027475 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,602,937

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This transaction represents the vesting on June 13, 2025 of 422,475 Restricted Stock Units ("RSUs") granted on June 13, 2024 under the Company's 2021 Equity Incentive Plan (as amended and restated on April 22, 2024) and reported on the Form 4 filed August 9, 2024. This relates to the vesting of the first of three equal annual installments (further details in Note 7 below). Each RSU represents the right to receive one share of Common Stock. These 422,475 RSUs were settled in shares of Common Stock on March 13, 2026.

F1 · price: This transaction represents the vesting on June 13, 2025 of 422,475 Restricted Stock Units ("RSUs") granted on June 13, 2024 under the Company's 2021 Equity Incentive Plan (as amended and restated on April 22, 2024) and reported on the Form 4 filed August 9, 2024. This relates to the vesting of the first of three equal annual installments (further details in Note 7 below). Each RSU represents the right to receive one share of Common Stock. These 422,475 RSUs were settled in shares of Common Stock on March 13, 2026.

SEC source: 0001213900-25-038457 · ownership.xml · derivative · entry 1

del Vecchio Peter · CIK 0002043884 · Interim CLO & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires not disclosed

F1 · derivative.exercise_price: The RSUs will be net settled in shares of Common Stock.

F2 · derivative.exercise_price: Each RSU represents a right to receive one share of Common Stock granted pursuant to the 2021 Equity Incentive Plan (amended and restated as of April 22, 2024).

F3 · derivative.exercise_date: The RSUs will all vest on May 4, 2025 and will be net settled within 30 days of the vesting date (i.e., by June 3, 2025).

F3 · derivative.expiration_date: The RSUs will all vest on May 4, 2025 and will be net settled within 30 days of the vesting date (i.e., by June 3, 2025).

SEC source: 0001213900-25-038456 · ownership.xml · derivative · entry 1

Calio Joseph Evan · CIK 0002027475 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,751,298

Underlying: Common Stock · 483,871 shares

Expires not disclosed

F1 · derivative.exercise_price: The RSUs will be net settled in shares of Common Stock.

F2 · derivative.exercise_price: Each RSU represents a right to receive one share of Common Stock granted pursuant to the 2021 Equity Incentive Plan (amended and restated as of April 22, 2024).

F3 · derivative.exercise_date: The RSUs will vest ratably over three years from the April 29, 2025 grant date. One-third (1/3) of the units shall vest on April 29, 2026. One-third (1/3) of the units shall vest on April 29, 2027. One-third (1/3) of the units shall vest on April 29, 2028.

F3 · derivative.expiration_date: The RSUs will vest ratably over three years from the April 29, 2025 grant date. One-third (1/3) of the units shall vest on April 29, 2026. One-third (1/3) of the units shall vest on April 29, 2027. One-third (1/3) of the units shall vest on April 29, 2028.

SEC source: 0001213900-25-094701 · ownership.xml · derivative · entry 1

Cruz Denise · CIK 0001586625 · SVP, CAO and Corp. Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Shares of Common Stock · 150,000 shares

Expires not disclosed

F1 · derivative.exercise_price: The RSUs will be net settled in shares of Common Stock.

F2 · derivative.exercise_price: Each RSU represents a right to receive one share of Common Stock granted pursuant to the 2021 Equity Incentive Plan (amended and restated as of April 22, 2024).

F3 · derivative.exercise_date: The RSUs will vest ratably over three years from the April 29, 2025 grant date. One-third (1/3) of the units shall vest on April 29, 2026. One-third (1/3) of the units shall vest on April 29, 2027. One-third (1/3) of the units shall vest on April 29, 2028.

F3 · derivative.expiration_date: The RSUs will vest ratably over three years from the April 29, 2025 grant date. One-third (1/3) of the units shall vest on April 29, 2026. One-third (1/3) of the units shall vest on April 29, 2027. One-third (1/3) of the units shall vest on April 29, 2028.

SEC source: 0001013762-25-002725 · ownership.xml · derivative · entry 6

Kilde Einar · CIK 0002033804 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,189 shares

Expires 2025-03-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: The stock options previously reported in the original Form 3 filed on August 19, 2024 (the "Form 3") were settled in cash, rather than the right to shares of Common Stock, as per the terms of the award following the expiration of a lock-up..

F3 · derivative.exercise_price: Due to an administrative error, the exercise price of this security was previously reported as $1.114 in the Form 3.

F4 · derivative.exercise_date: Due to an administrative error, the exercise date of this security was previously reported as vesting in one-thirds (1/3) annually over three years beginning on the grant date in 2021 in the Form 3 rather than immediately upon grant.

F5 · derivative.expiration_date: Due to an administrative error, the expiration date of this security was previously reported as January 29, 2026 on the Form 3.

SEC source: 0001013762-25-002725 · ownership.xml · derivative · entry 5

Kilde Einar · CIK 0002033804 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 22,378 shares

Expires 2025-03-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: The stock options previously reported in the original Form 3 filed on August 19, 2024 (the "Form 3") were settled in cash, rather than the right to shares of Common Stock, as per the terms of the award following the expiration of a lock-up..

F4 · derivative.exercise_date: Due to an administrative error, the exercise date of this security was previously reported as vesting in one-thirds (1/3) annually over three years beginning on the grant date in 2021 in the Form 3 rather than immediately upon grant.

F5 · derivative.expiration_date: Due to an administrative error, the expiration date of this security was previously reported as January 29, 2026 on the Form 3.

SEC source: 0001013762-25-002725 · ownership.xml · nonDerivative · entry 4

Kilde Einar · CIK 0002033804 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The stock options were settled in cash as per the terms of the award. For reporting purposes, however, the transaction is deemed to be a simultaneous acquisition and disposition of the underlying shares of Common Stock and is reflected as such in this report.

SEC source: 0001013762-25-002725 · ownership.xml · nonDerivative · entry 3

Kilde Einar · CIK 0002033804 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,189

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock options were settled in cash as per the terms of the award. For reporting purposes, however, the transaction is deemed to be a simultaneous acquisition and disposition of the underlying shares of Common Stock and is reflected as such in this report.

SEC source: 0001013762-25-002725 · ownership.xml · nonDerivative · entry 2

Kilde Einar · CIK 0002033804 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The stock options were settled in cash as per the terms of the award. For reporting purposes, however, the transaction is deemed to be a simultaneous acquisition and disposition of the underlying shares of Common Stock and is reflected as such in this report.

SEC source: 0001013762-25-002725 · ownership.xml · nonDerivative · entry 1

Kilde Einar · CIK 0002033804 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,378

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock options were settled in cash as per the terms of the award. For reporting purposes, however, the transaction is deemed to be a simultaneous acquisition and disposition of the underlying shares of Common Stock and is reflected as such in this report.

SEC source: 0001213900-25-000774 · ownership.xml · derivative · entry 2

Calio Joseph Evan · CIK 0002027475 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,267,427

Underlying: Shares of Common Stock · 1,000,000 shares

Expires not disclosed

F2 · derivative.exercise_price: The RSUs will be net settled in shares of Common Stock.

F3 · derivative.exercise_price: Each RSU represents a right to receive one share of Common Stock granted pursuant to the FREYR Battery, Inc. 2021 Equity Incentive Plan (as amended and restated).

F2 · price: The RSUs will be net settled in shares of Common Stock.

F4 · derivative.exercise_date: The RSUs will vest ratably on an accelerated basis from the January 1, 2025 grant date. One-third (1/3) of the units vested on January 1, 2025. One-third (1/3) of the units shall vest on January 1, 2026. One-third (1/3) of the units shall vest on January 1, 2027.

F4 · derivative.expiration_date: The RSUs will vest ratably on an accelerated basis from the January 1, 2025 grant date. One-third (1/3) of the units vested on January 1, 2025. One-third (1/3) of the units shall vest on January 1, 2026. One-third (1/3) of the units shall vest on January 1, 2027.

SEC source: 0001213900-25-000774 · ownership.xml · nonDerivative · entry 1

Calio Joseph Evan · CIK 0002027475 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,180,462

F1 · shares: Consists of RSUs vested on the date of issuance.

F2 · price: The RSUs will be net settled in shares of Common Stock.

SEC source: 0001213900-25-000773 · ownership.xml · derivative · entry 2

Barcelo Daniel · CIK 0001786389 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,041,666

Underlying: Shares of Common Stock · 666,667 shares

Expires not disclosed

F2 · derivative.exercise_price: The RSUs will be net settled in shares of Common Stock.

F3 · derivative.exercise_price: Each RSU represents a right to receive one share of Common Stock granted pursuant to the FREYR Battery, Inc. 2021 Equity Incentive Plan (as amended and restated).

F2 · price: The RSUs will be net settled in shares of Common Stock.

F4 · derivative.exercise_date: The RSUs will vest ratably on an accelerated basis from the January 1, 2025 grant date. One-third (1/3) of the units vested on January 1, 2025. One-third (1/3) of the units shall vest on January 1, 2026. One-third (1/3) of the units shall vest on January 1, 2027.

F4 · derivative.expiration_date: The RSUs will vest ratably on an accelerated basis from the January 1, 2025 grant date. One-third (1/3) of the units vested on January 1, 2025. One-third (1/3) of the units shall vest on January 1, 2026. One-third (1/3) of the units shall vest on January 1, 2027.

SEC source: 0001213900-25-000773 · ownership.xml · nonDerivative · entry 1

Barcelo Daniel · CIK 0001786389 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 808,333

F1 · shares: Consists of RSUs vested on the date of issuance.

F2 · price: The RSUs will be net settled in shares of Common Stock.

SEC source: 0000921895-24-003040 · form409900010_12272024.xml · derivative · entry 1

Encompass Capital Advisors LLC · CIK 0001541901 · Director · See Remarks

Kantor Todd J. · CIK 0002021082 · Director · See Remarks

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000,000

Underlying: Common Stock · 20,000,000 shares

Expires 2027-12-23

F1 · security: This Form 4 is filed jointly by Todd Kantor, Encompass Capital Advisors LLC ("ECA") and Encompass Capital Partners LLC ("ECP" and, together with Mr. Kantor and ECA, collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a Section 13(d) group. Each of the Reporting Persons disclaims beneficial ownership of the securities of the Issuer owned directly by other members of the Section 13(d) group and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Further, each of the Reporting Persons disclaims beneficial ownership of the shares of Common Stock reported herein except to the extent of his or its pecuniary interest therein.

F2 · derivative.exercise_price: Each share of Series A Convertible Preferred Stock, par value $0.01 per share ("Preferred Stock") is convertible at any time after December 23, 2025 into a number of shares of common stock of the Issuer ("Common Stock") equal to the sum of the issue price ($10.00) plus any accrued but unpaid dividends divided by the conversion price (initially $2.50, but subject to adjustment to $1.79 in the event the Issuer elects not to issue the Second Tranche on the date that the Issuer proceeds with its final investment decision with respect to the TUM 2 facility, as defined in the certificate of designations of the Preferred Stock (the "Certificate")). The Certificate prohibits conversion to the extent that the holder would beneficially own in excess of 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of Preferred Stock.

F2 · derivative.exercise_date: Each share of Series A Convertible Preferred Stock, par value $0.01 per share ("Preferred Stock") is convertible at any time after December 23, 2025 into a number of shares of common stock of the Issuer ("Common Stock") equal to the sum of the issue price ($10.00) plus any accrued but unpaid dividends divided by the conversion price (initially $2.50, but subject to adjustment to $1.79 in the event the Issuer elects not to issue the Second Tranche on the date that the Issuer proceeds with its final investment decision with respect to the TUM 2 facility, as defined in the certificate of designations of the Preferred Stock (the "Certificate")). The Certificate prohibits conversion to the extent that the holder would beneficially own in excess of 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of Preferred Stock.

F2 · ownership.direct: Each share of Series A Convertible Preferred Stock, par value $0.01 per share ("Preferred Stock") is convertible at any time after December 23, 2025 into a number of shares of common stock of the Issuer ("Common Stock") equal to the sum of the issue price ($10.00) plus any accrued but unpaid dividends divided by the conversion price (initially $2.50, but subject to adjustment to $1.79 in the event the Issuer elects not to issue the Second Tranche on the date that the Issuer proceeds with its final investment decision with respect to the TUM 2 facility, as defined in the certificate of designations of the Preferred Stock (the "Certificate")). The Certificate prohibits conversion to the extent that the holder would beneficially own in excess of 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of Preferred Stock.

SEC source: 0000921895-24-003057 · form4a09900010_12312024.xml · derivative · entry 1

Encompass Capital Advisors LLC · CIK 0001541901 · Director · See Remarks

Kantor Todd J. · CIK 0002021082 · Director · See Remarks

Encompass Capital Partners LLC · CIK 0002050318 · Director · See Remarks

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000,000

Underlying: Common Stock · 20,000,000 shares

Expires 2027-12-23

F1 · security: This Form 4/A is filed jointly by Todd Kantor, Encompass Capital Advisors LLC ("ECA") and Encompass Capital Partners LLC ("ECP" and, together with Mr. Kantor and ECA, collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a Section 13(d) group. Each of the Reporting Persons disclaims beneficial ownership of the securities of the Issuer owned directly by other members of the Section 13(d) group and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Further, each of the Reporting Persons disclaims beneficial ownership of the shares of Common Stock reported herein except to the extent of his or its pecuniary interest therein.

F2 · derivative.exercise_price: Each share of Series A Convertible Preferred Stock, par value $0.01 per share ("Preferred Stock") is convertible at any time after December 23, 2025 into a number of shares of common stock of the Issuer ("Common Stock") equal to the sum of the issue price ($10.00) plus any accrued but unpaid dividends divided by the conversion price (initially $2.50, but subject to adjustment to $1.79 in the event the Issuer elects not to issue the Second Tranche on the date that the Issuer proceeds with its final investment decision with respect to the TUM 2 facility, as defined in the certificate of designations of the Preferred Stock (the "Certificate")). The Certificate prohibits conversion to the extent that the holder would beneficially own in excess of 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of Preferred Stock.

F2 · derivative.exercise_date: Each share of Series A Convertible Preferred Stock, par value $0.01 per share ("Preferred Stock") is convertible at any time after December 23, 2025 into a number of shares of common stock of the Issuer ("Common Stock") equal to the sum of the issue price ($10.00) plus any accrued but unpaid dividends divided by the conversion price (initially $2.50, but subject to adjustment to $1.79 in the event the Issuer elects not to issue the Second Tranche on the date that the Issuer proceeds with its final investment decision with respect to the TUM 2 facility, as defined in the certificate of designations of the Preferred Stock (the "Certificate")). The Certificate prohibits conversion to the extent that the holder would beneficially own in excess of 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of Preferred Stock.

F2 · ownership.direct: Each share of Series A Convertible Preferred Stock, par value $0.01 per share ("Preferred Stock") is convertible at any time after December 23, 2025 into a number of shares of common stock of the Issuer ("Common Stock") equal to the sum of the issue price ($10.00) plus any accrued but unpaid dividends divided by the conversion price (initially $2.50, but subject to adjustment to $1.79 in the event the Issuer elects not to issue the Second Tranche on the date that the Issuer proceeds with its final investment decision with respect to the TUM 2 facility, as defined in the certificate of designations of the Preferred Stock (the "Certificate")). The Certificate prohibits conversion to the extent that the holder would beneficially own in excess of 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of Preferred Stock.

SEC source: 0001213900-24-111191 · ownership.xml · nonDerivative · entry 1

Slettemoen Tore Ivar · CIK 0002020977 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 5,080,446

F1 · ownership.nature: Teknovekst UK Ltd, incorporated in the United Kingdom ("Teknovekst UK"), directly holds 5,080,446 shares of Common Stock, whose sole shareholder is Teknnovekst Invest AS, incorporated in Norway ("Teknovekst Invest"). Teknovekst AS, also incorporated in Norway, may be deemed to beneficially own the shares held by Teknovekst UK by virtue of its 99.9% ownership of Teknovekst Invest. Mr. Slettemoen is the sole owner of Teknovekst AS and disclaims beneficial ownership of the shares held by Teknovekst AS except to the extent of his pecuniary interest therein.